Novartis Escapes End Payors' Gleevec Antitrust Suit
A Massachusetts federal judge on Friday granted Novartis Pharmaceuticals Corp.'s bid to toss a proposed class action alleging the company participated in an anti-competitive scheme to extend its monopoly on leukemia...To view the full article, register now.
Already a subscriber? Click here to view full article